Longer Duration of Treatment with ICIs Associated with a Higher Rate of Complete Response Among Patients with MMRd Cancers By Ogkologos - March 5, 2025 667 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a systematic review of published studies Source RELATED ARTICLESMORE FROM AUTHOR EMA Adopts a Positive Opinion for a New Route of Administration Together with a New Pharmaceutical Form and a New Strength for Isatuximab National Study Examines Genetic Testing to Inform Follow-up Care for Cancer Survivors Taletrectinib Demonstrates Durable Long-Term Efficacy in Both TKI-naïve and Crizotinib-pretreated Patients with Advanced ROS1-positive NSCLC MOST POPULAR FDA Approves New Initial Treatment Option for Some Metastatic Prostate Cancers August 4, 2023 Higher Risk of Heart Failure Seen in Some Cancers March 26, 2018 How to Make a Homemade Face Mask from a Folded Scarf—No... April 29, 2020 Young Woman’s Breast Cancer Diagnosis Ends Up Saving Her Mom’s Life... September 27, 2021 Load more HOT NEWS Can Chemo Help KRAS Inhibitors Work Better Against Pancreatic Cancer? 177Lu-PSMA-617 Prolongs rPFS Relative to Androgen Receptor Pathway Inhibitor Change, with... How MRI add-ons could accelerate the development of new treatments Shorter Course of Radiation Is Effective, Safe for Some with Early-Stage...
